Last session

November 12, 2026

DigitalBridge won the final regulatory green light for its acquisition by SoftBank, clearing the last hurdle on a deal worth roughly $500 billion.

What happened

DigitalBridge received all regulatory approvals required to complete its buyout by SoftBank Group Corp. No outstanding conditions remain. The deal, along with Angelini Pharma’s completed acquisition of Catalyst Pharmaceuticals, was the largest mover in markets today, together shifting around half a trillion dollars of market value.

Why it matters

Regulatory risk is the last thing that can blow up an agreed deal at this stage. With that box checked, arbitrage spreads collapse and the certainty of closing rewrites both companies’ capital plans. For a transaction this large, the resolution ripples through the lenders and counterparties that have been waiting on the final sign off, freeing committed financing and removing an overhang from the acquirer’s balance sheet.

The case against

A clean approval was widely expected after the parties addressed earlier concerns, so the news may already be in the stock. SoftBank still has to integrate DigitalBridge’s portfolio while managing its own large debt load, and a deal this large locks in the purchase price regardless of what the economy does next.

What settles it

The closing date and whether SoftBank replaces DigitalBridge’s existing credit facilities with permanent financing in the quarter after completion.

Companies in this story

All market stories

Decifer Markets is a media publication. Nothing here is investment advice, a recommendation, or an offer to buy or sell any security.

DisclaimerTermsPrivacyAbout